ISRCTN ISRCTN33931714
DOI https://doi.org/10.1186/ISRCTN33931714
Protocol serial number N0060187568
Sponsor Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Funder Chelsea and Westminster Healthcare NHS Trust (UK)
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
11/10/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Steve Yentis
Scientific

Magill Dept of Anaesthesia, Intensive Care & Pain Management
Chelsea and Westminster Hospital
369 Fulham Road
London
SW10 9NH
United Kingdom

Phone +44 (0)20 8746 8026
Email s.yentis@imperial.ac.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesDoes providing warmed intravenous fluid at elective caesarean section reduce the incidence of hypothermia and improve maternal thermal comfort?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedPregnancy and Childbirth: Caesarean section
InterventionWarmed intravenous fluid vs no warmed intravenous fluid
Intervention typeOther
Primary outcome measure(s)

Core body temperature, incidence and severity of shivering and pain (Visual Analogue Scale), thermal comfort score (visual analogue scale), fetal Apgar scores and umbilical cord blood gas measurements (routinely performed at caesarean section)

Key secondary outcome measure(s)

1. Shivering
2. Self-reported thermal comfort

Completion date01/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target sample size at registration75
Key inclusion criteriaHealthy women with uncomplicated single pregnancy of > 37 weeks’ gestation due for elective caesarean section
Key exclusion criteria1. Pyrexia
2. Inability to take non-steroidal anti-inflammatory (NSAIDs) medication
3. Pre-eclampsia/eclampsia
4. Drug therapy other than antacids and vitamins/minerals
5. Increased risk of intra-operative haemorrhage (eg placenta praevia or accreta).
Date of first enrolment25/10/2006
Date of final enrolment01/12/2007

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Magill Dept of Anaesthesia, Intensive Care & Pain Management
London
SW10 9NH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2009 Yes No